Recent advances in fluorination techniques and their anticipated impact on drug metabolism and toxicity

Bibliography

• Fried J, Sabo EF. 9-Alpha-fluoro derivatives of cortisone and hydrocortisone. J Am Chem Soc 1954;76:1455-6
   Web of Science ®Google Scholar
• Ilardi EA, Vitaku E, Njardarson JT. Data-mining for sulfur and fluorine: an evaluation of pharmaceuticals to reveal opportunities for drug design and discovery. J Med Chem 2014;57:2832-42
   PubMed Web of Science ®Google Scholar
• FDA. FY 2012 Innovative Drug Approvals. 2012. Available from: http://www.fda.gov/AboutFDA/ReportsManualsForms/Reports/ucm276385.htm
   Google Scholar
• Mullin R. Before the storm. Chem Eng News 2011;89:12-18
   Web of Science ®Google Scholar
• Harper DB, O’Hagan D. The fluorinated natural products. Nat Prod Rep 1994;11:123-33
   PubMed Web of Science ®Google Scholar
• Purser S, Moore PR, Swallow S, Gouverneur V. Fluorine in medicinal chemistry. Chem Soc Rev 2008;37:320-30
   PubMed Web of Science ®Google Scholar
• Kirk KL. Fluorination in medicinal chemistry: methods, strategies, and recent developments. Org Process Res Dev 2008;12:305-21
   Web of Science ®Google Scholar
• Malet-Martino M, Gilard W, Desmoulin F, Martino R. Fluorine nuclear magnetic resonance spectroscopy of human biofluids in the field of metabolic studies of anticancer and antifungal fluoropyrimidine drugs. Clin Chim Acta 2006;366:61-73
   PubMed Web of Science ®Google Scholar
• Peters RA. Lethal synthesis. Proc Natl Acad Sci USA 1952;139:143-70
   Google Scholar
• Lauble H, Kennedy MC, Emptage MH, et al. The reaction of fluorocitrate with aconitase and the crystal structure of the enzyme-inhibitor complex. Proc Natl Acad Sci USA 1996;93:13699-703
   PubMed Web of Science ®Google Scholar
• Kirsten E, Sharma ML, Kun E. Molecular toxicology of (-)-erythro-fluorocitrate - selective-inhibition of citrate transport in mitochondria and binding of fluorocitrate to mitochondrial proteins 15. Mol Pharmacol 1978;14:172-84
   PubMed Web of Science ®Google Scholar
• Paulini R, Muller K, Diederich F. Orthogonal multipolar interactions in structural chemistry and biology. Angew Chem Int Ed Engl 2005;44:1788-805
   PubMed Web of Science ®Google Scholar
• Muller K, Faeh C, Diederich F. Fluorine in pharmaceuticals: looking beyond intuition. Science 2007;3170:1881-6
   Google Scholar
• Bottomley MJ, Lo Surdo P, Di Giovine P, et al. Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain. J Biol Chem 2008;283:26694-704
   PubMed Web of Science ®Google Scholar
• Smart BE. Fluorine substituent effects (on bioactivity). J Fluor Chem 2001;109:3-11
   Web of Science ®Google Scholar
• Gerebtzoff G, Li-Blatter X, Fischer H, et al. Halogenation of drugs enhances membrane binding and permeation. ChemBioChem 2004;5:676-84
   PubMed Web of Science ®Google Scholar
• Rowley M, Hallett DJ, Goodacre S, et al. 3-(4-fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT2A receptor antagonist. J Med Chem 2001;44:1603-14
   PubMed Web of Science ®Google Scholar
• Manoharan M, Akinc A, Pandey RK, et al. Unique gene-silencing and structural properties of 2 ’-fluoro-modified siRNAs. Angew Chem Int Ed Engl 2011;50:2284-8
   PubMed Web of Science ®Google Scholar
• Blanksby SJ, Ellison GB. Bond dissociation energies of organic molecules. Acc Chem Res 2003;36:255-63
   PubMed Web of Science ®Google Scholar
• Clader JW. The discovery of ezetimibe: a view from outside the receptor. J Med Chem 2003;47:1-9
   Web of Science ®Google Scholar
• Park BK, Kitteringham NR, O’Neill PM. Metabolism of fluorine-containing drugs. Annu Rev Pharmacol Toxicol 2001;41:443-70
   PubMed Web of Science ®Google Scholar
• Pekala E, Kubowicz P, Lazewska D. Cunninghamella as a microbiological model for metabolism of histamine H-3 receptor antagonist 1- 3-(4-tert-butylphenoxy)propyl piperidine. Appl Biochem Biotechnol 2012;168:1584-93
   PubMed Web of Science ®Google Scholar
• Bright TV, Dalton F, Elder VL, et al. A convenient chemical-microbial method for developing fluorinated pharmaceuticals. Org Biomol Chem 2013;11:1135-42
   PubMed Web of Science ®Google Scholar
• Shaughnessey MJ, Harsanyi A, Li J, et al. Targetted fluorination of a non-steroidal anti-inflammatory drug to prolong metabolic half life. ChemMedChem 2014;9:733-6
   PubMed Web of Science ®Google Scholar
• Barbier O, Arreola-Mendoza L, Del Razo LM. Molecular mechanisms of fluoride toxicity. Chem Biol Interact 2010;188:319-33
   PubMed Web of Science ®Google Scholar
• Shang J, Xu S, Teffera Y, et al. Metabolic activation of a pentafluorophenylethylamine derivative: formation of glutathione conjugates in vitro in the rat. Xenobiotica 2005;35:697-713
   PubMed Web of Science ®Google Scholar
• Wermers RA, Cooper K, Razonable RR, et al. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy. Clin Infect Dis 2011;52:604-11
   PubMed Web of Science ®Google Scholar
• Wandel C, Neff S, Keppler G, et al. The relationship between cytochrome P4502E1 activity and plasma fluoride levels after sevoflurane anesthesia in humans. Anesth Analg 1997;85:924-30
   PubMed Web of Science ®Google Scholar
• Sandford G. Fluoroarenes. In: Ramsden CA, editor. Science of synthesis houben-weyl methods of molecular transformations. Thieme; Stuttgart: 2007. p. 21-78
   Google Scholar
• Sandford G. Trihalides. In: Katritzky AR, Rees CJ, editors. Comprehensive organic functional group transformations 2. Elsevier; Amsterdam: 2004. p. 1-22
   Google Scholar
• Butters M, Ebbs J, Green SP, et al. Process development of voriconazole: a novel broad-spectrum triazole antifungal agent. Org Process Res Dev 2000;5:28-36
   Web of Science ®Google Scholar
• Bowden RD, Comina PJ, Greenhall MP, et al. A new method for the synthesis of aromatic sulfurpentafluorides and studies of the stability of the sulfurpentafluoride group in common synthetic transformations. Tetrahedron 2000;56:3399-408
   Web of Science ®Google Scholar
• Altomonte S, Zanda M. Synthetic chemistry and biological activity of pentafluorosulphanyl (SF5) organic molecules. J Fluor Chem 2012;143:57-93
   Web of Science ®Google Scholar
• Sergeeva TA, Dolbier WR. A new synthesis of pentafluorosulfanylbenzene. Org Lett 2004;6:2417-19
   PubMed Web of Science ®Google Scholar
• Umemoto T, Garrick LM, Saito N. Discovery of practical production processes for arylsulfur pentafluorides and their higher homologues, bis- and tris(sulfur pentafluorides): beginning of a new era of “super-trifluoromethyl” arene chemistry and its industry. Beilstein J Org Chem 2012;8:461-71
   PubMed Web of Science ®Google Scholar
• Welch JT, Lim DS. The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine. Bioorg Med Chem 2007;15:6659-66
   PubMed Web of Science ®Google Scholar
• Wipf P, Mo T, Geib SJ, et al. Synthesis and biological evaluation of the first pentafluorosulfanyl analogs of mefloquine. Org Biomol Chem 2009;7:4163-5
   PubMed Web of Science ®Google Scholar
• Mo T, Mi X, Milner EE, et al. Synthesis of an 8-pentafluorosulfanyl analog of the antimalarial agent mefloquine. Tetrahedron Lett 2010;51:5137-40
   Web of Science ®Google Scholar
• Dow GS, Milner EE, Wipf P, Mo T. Derivatives of mefloquine and associated methods for making and using. WO144434A1; 2010
   Google Scholar
• Umemoto T, Singh RP, Xu Y, Saito N. Discovery of 4-tert-butyl-2,6-dimethylphenylsulfur trifluoride as a deoxofluorinating agent with high thermal stability as well as unusual resistance to aqueous hydrolysis, and its diverse fluorination capabilities including deoxofluoro-arylsulfinylation with high stereoselectivity. J Am Chem Soc 2010;132:18199-205
   PubMed Web of Science ®Google Scholar
• Moran S, Rai DK, Clark BR, Murphy CD. Precursor-directed biosynthesis of fluorinated iturin A in Bacillus spp. Org Biomol Chem 2009;7:644-6
   PubMed Web of Science ®Google Scholar
• O’Connor N, Hudson A, Cobb S, et al. Novel fluorinated lipopeptides from Bacillus sp. CS93 via precursor-directed biosynthesis. Amino Acids 2014;46:2745-52
   PubMed Web of Science ®Google Scholar
• O’Connor NK, Rai DK, Clark BR, Murphy CD. Production of the novel lipopeptide antibiotic trifluorosurfactin via precursor-directed biosynthesis. J Fluor Chem 2012;143:210-15
   Web of Science ®Google Scholar
• Eustaquio AS, Moore BS. Mutasynthesis of fluorosalinosporamide, a potent and reversible inhibitor of the proteasome. Angew Chem Int Ed Engl 2008;47:3936-8
   PubMed Web of Science ®Google Scholar
• Groll M, Huber R, Potts BCM. Crystal structures of salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of beta-lactone ring opening and a mechanism for irreversible binding. J Am Chem Soc 2006;128:5136-41
   PubMed Web of Science ®Google Scholar
• Groll M, McArthur KA, Macherla VR, et al. Snapshots of the fluorosalinosporamide/20S complex offer mechanistic insights for fine tuning proteasome inhibition. J Med Chem 2009;52:5420-8
   PubMed Web of Science ®Google Scholar
• O’Hagan D, Schaffrath C, Cobb SL, et al. Biosynthesis of an organofluorine molecule - a fluorinase enzyme has been discovered that catalyses carbon-fluorine bond formation. Nature 2002;416:279-9
   PubMed Web of Science ®Google Scholar
• Deng H, Ma L, Bandaranayaka N, et al. Identification of fluorinases from Streptomyces sp MA37, Norcardia brasiliensis, and Actinoplanes sp N902-109 by genome mining. ChemBioChem 2014;15:364-8
   PubMed Web of Science ®Google Scholar
• Huang S, Ma L, Tong MH, et al. Fluoroacetate biosynthesis from the marine-derived bacterium Streptomyces xinghaiensis NRRL B-24674. Org Biomol Chem 2014;12:4828-31
   PubMed Web of Science ®Google Scholar
• Eustaquio AS, O’Hagan D, Moore BS. Engineering fluorometabolite production: fluorinase expression in Salinispora tropica yields fluorosalinosporamide. J Nat Prod 2010;73:378-82
   PubMed Web of Science ®Google Scholar
• Walker MC, Thuronyi BW, Charkoudian LK, et al. Expanding the fluorine chemistry of living systems using engineered polyketide synthase pathways. Science 2013;341:1089-94
   PubMed Web of Science ®Google Scholar
• Rentmeister A, Arnold FH, Fasan R. Chemo-enzymatic fluorination of unactivated organic compounds. Nat Chem Biol 2009;5:26-8
   PubMed Web of Science ®Google Scholar
• Domagala JM, Hanna LD, Heifetz CL, et al. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay. J Med Chem 1986;29:394-404
   PubMed Web of Science ®Google Scholar
• Halperin SD, Fan H, Chang S, et al. A convenient photocatalytic fluorination of unactivated C-H bonds. Angew Chem Int Ed 2014;53:4690-3
   PubMed Web of Science ®Google Scholar
• Breen JR, Sandford G, Yufit DS, et al. Continuous gas/liquid–liquid/liquid flow synthesis of 4-fluoropyrazole derivatives by selective direct fluorination. Beilstein J Org Chem 2011;7:1048-54
   PubMed Web of Science ®Google Scholar
• Ji Y, Brueckl T, Baxter RD, et al. Innate C-H trifluoromethylation of heterocycles. Proc Natl Acad Sci USA 2011;108:14411-15
   PubMed Web of Science ®Google Scholar
• Kosjek T, Perko S, Žigon D, Heath E. Fluorouracil in the environment: analysis, occurrence, degradation and transformation. J Chromatogr A 2013;1290:62-72
   PubMed Web of Science ®Google Scholar
• Jackson DA, Mabury SA. Environmental properties of pentafluorosulfanyl compounds: physical properties and photodegradation. Environ Toxicol Chem 2009;28:1866-73
   PubMed Web of Science ®Google Scholar
• Kavanagh E, Winn M, Gabhann CN, et al. Microbial biotransformation of aryl sulfanylpentafluorides. Environ Sci Pollut Res Int 2014;21:753-8
   PubMed Web of Science ®Google Scholar
• Van Heek M, France CF, Compton DS, et al. In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. J Pharmacol Exp Ther 1997;283:157-63
   PubMed Web of Science ®Google Scholar